ARCHIVES

Arimidex Gets Full Approval For HR+ Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

Virus Studies Approved By DCE Board for $2.5 Mil. In First Year

November 3, 1989

Oncologists Don’t Demand Increased Survival When Ordering Expensive Drugs, Survey Finds

April 13, 2012

NCI Needs 100 SBIR Contracts By April 1 To Avoid Losing $5 Million; NIH Objects To DCT Comments

March 22, 1985

In Brief: DeVita Receives Griffuel Prize; Commission On Ethics To Take Up Compensation Question

December 12, 1980

Combination of Pill, Pap Test, May Result In False Positive

February 27, 2004